about
An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South AfricaHigh prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin.Population snapshot of Streptococcus pneumoniae causing invasive disease in South Africa prior to introduction of pneumococcal conjugate vaccines.Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.Challenges of using molecular serotyping for surveillance of pneumococcal disease.Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogensGenomic analysis of nontypeable pneumococci causing invasive pneumococcal disease in South Africa, 2003-2013Two cases of serotypeable and non-serotypeable variants of Streptococcus pneumoniae detected simultaneously during invasive diseasePopulation snapshot of invasive serogroup B meningococci in South Africa from 2005 to 2008Understanding pneumococcal serotype 1 biology through population genomic analysis.Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.Molecular characterization of invasive capsule null Neisseria meningitidis in South AfricaClonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688.Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden.Phylogenetic Analysis of Invasive Serotype 1 Pneumococcus in South Africa, 1989 to 2013.Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005.Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa.In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa.Meningococcal disease in South Africa, 1999-2002.The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1.Molecular Characterization of Corynebacterium diphtheriae Outbreak Isolates, South Africa, March-June 2015Enterovirus genotypes among patients with severe acute respiratory illness, influenza-like illness, and asymptomatic individuals in South Africa, 2012-2014.High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia.HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011.Invasive Neisseria meningitidis with decreased susceptibility to fluoroquinolones in South Africa, 2009.Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009.In vitro activity of faropenem against respiratory pathogens.Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa.Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa.Invasive disease caused simultaneously by dual serotypes of Streptococcus pneumoniae.Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa.Single report of β-lactam resistance in an invasive Haemophilus influenzae isolate from South Africa mediated by mutations in penicillin-binding protein 3, 2003-2008.Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005.Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015.Prevalence of DHPS polymorphisms associated with sulfa resistance in South African Pneumocystis jirovecii strains.Global Distribution of Invasive Serotype 35D Streptococcus pneumoniae Isolates following Introduction of 13-Valent Pneumococcal Conjugate Vaccine.Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults
P50
Q33614192-37AF3D4D-B1DD-4FB8-9A0B-EB02D53A3865Q33909311-AEF684C5-69F9-435B-B3ED-302E598CDD8BQ34110986-AEEB2281-88E0-4263-97F0-DF3C674E5526Q34215103-54155CA4-C90B-44B2-8FB6-6A7F88814F37Q34764110-A5CA03DA-63D3-4BC9-B4EC-1B5AB496F211Q35035741-8CEC3B23-412A-4EDD-B6A6-E6919CA9550CQ35806833-C0B48BB4-2649-49EE-9953-0DD31A0EF4E3Q36059290-DDB59618-3422-4438-B858-CD1B9D6FCFBAQ36061279-339AE83E-55DB-4DC8-914B-335240B08CD6Q36171431-B885D92B-F5E5-44B7-B09E-3C99487B2969Q36184872-E9E1D2FE-5993-4C8A-8CDF-31AB8BB6FB0AQ36254505-9888FED2-5223-4365-9980-159513389808Q36286634-00615DEF-D975-44D7-8250-E17B80F2FF01Q36363154-D5A463C2-EED9-41AA-9269-524E1ECEECCCQ36559132-2EF43FB8-D873-40A4-9FDC-3EC0ECF74E59Q36834725-15893549-4609-464D-828C-4CD83BFB6A10Q36933476-6950B1DA-0F3E-43D4-B36F-1DF4D362EF8EQ37063835-2AD99CB8-E3E6-4F7B-A6E0-4093C248442BQ37072096-EA490D18-2DAF-4E6F-82C8-BE9E15EF5049Q37191555-1CB194E6-9250-4648-BBD4-0E5714978EEFQ37302664-EBD5A67B-E003-4D8A-AB47-EC33B2B0D3D3Q37619104-6540C94F-AEF3-42D2-B941-99163801B2EAQ38372999-B0548231-D032-49D8-B009-245675381B5EQ40175903-2105B8DC-FCB1-4023-B271-9EE4F6DC38C1Q42211643-2360DFDE-0E03-469E-B590-F45B4E5181B6Q42278517-C364ABF0-DDFA-46C2-A0D4-B5E262EEA4A7Q42944997-E0AB8B3B-032C-4529-AE9B-CCA0F3697911Q43590365-4181C048-7CA7-4866-B58E-F59BCF8339BFQ43895685-C1B06FF5-D318-4D52-A095-EAD16C0249E1Q45121011-AD2AA412-F24F-4BF2-AB51-B1EE81291A9BQ45391902-2677DBE3-6261-4B4C-A412-CF9BF68899BAQ46236173-BB1CE6B9-9DDA-48B9-80DE-6C0E99E4A0A2Q46242483-D86A3898-019C-4027-8826-DCC266B54F9AQ46524859-F0C74824-211C-41D9-8698-5BE62C8C0B3FQ46777542-DBBDF2E8-E943-4439-A932-F1C8493C3204Q46781559-70D6F8C9-D397-49A2-90DC-0DE9D68C1537Q49820170-BE992C46-FEAB-48E5-A2D0-EF270CEB62BFQ54567271-EE5D7744-81DD-4C12-8264-B08629A5759CQ55399661-670F5EE3-886B-474D-86E0-3964198C4F20Q58082020-09A54954-542F-4DB4-8097-709BA0849245
P50
description
researcher ORCID ID = 0000-0001-9186-0679
@en
wetenschapper
@nl
name
Mignon du Plessis
@ast
Mignon du Plessis
@en
Mignon du Plessis
@es
Mignon du Plessis
@nl
type
label
Mignon du Plessis
@ast
Mignon du Plessis
@en
Mignon du Plessis
@es
Mignon du Plessis
@nl
prefLabel
Mignon du Plessis
@ast
Mignon du Plessis
@en
Mignon du Plessis
@es
Mignon du Plessis
@nl
P106
P1153
7005744660
P31
P496
0000-0001-9186-0679